Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009

Lookup NU author(s): Emerita Professor Katherine Bushby, Emma HeslopORCiD, Dr Pauline McCormack, Emeritus Professor Simon WoodsORCiD

Downloads

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Elsevier, 2010.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Muntoni F, Contributors include, Bushby K, Heslop E, McCormack P, Woods S

Publication type: Article

Publication status: Published

Journal: Neuromuscular Disorders

Year: 2010

Volume: 20

Issue: 5

Pages: 355-362

Print publication date: 26/03/2010

Date deposited: 06/06/2013

ISSN (print): 0960-8966

ISSN (electronic): 1873-2364

Publisher: Elsevier

URL: http://dx.doi.org/10.1016/j.nmd.2010.03.005

DOI: 10.1016/j.nmd.2010.03.005

Notes: Report authored by Francesco Muntoni, on behalf of the meeting steering committee, and of the TREAT-NMD Network. Contributors to this document include: Kate Bushby (Institute of Human Genetics, Newcastle University); Emma Heslop (Institute of Human Genetics, Newcastle University); Pauline McCormack (Policy, Ethics and Life Sciences, Newcastle University); and Simon Woods (Policy, Ethics and Life Sciences, Newcastle University).

Altmetrics

Altmetrics provided by Altmetric

Share